Why the study?
Does acute inhalation exposure to COREXIT EC9500A alter cardiovascular and peripheral vascular functions in rats?
Does acute inhalation exposure to COREXIT EC9500A alter cardiovascular and peripheral vascular functions in rats?
Acute inhalation exposure to the oil dispersant COREXIT EC9500A causes transient increases in cardiovascular reactivity and vascular tone in rats.
Transient rat cardiovascular reactivity after dispersant exposure; leaves open human risk assessment.
These studies characterized cardiovascular responses after an acute inhalation exposure to COREXIT EC9500A, the oil dispersant used in the Deepwater Horizon oil spill. Male Sprague-Dawley rats underwent a single 5-h inhalation exposure to COREXIT EC9500A (average exposure level 27.12 mg/m(3)) or air. On d 1 and 7 following the exposure, rats were implanted with indwelling catheters and changes in heart rate and blood pressure were assessed in response to increasing levels of adrenoreceptor agonists. A separate group of rats was euthanized at the same time points, ventral tail arteries were dissected, and vascular tone along with dose-dependent responses to vasoconstricting and dilating factors were assessed in vitro. Agonist-induced dose-dependent increases in heart rate and blood pressure were greater in COREXIT EC9500A-exposed than in air-exposed rats at 1 d but not 7 d after the exposure. COREXIT EC9500A exposure also induced a rise in basal tone and reduced responsiveness of tail arteries to acetylcholine-induced vasodilation at 1 d but not 7 d following the exposure. These findings demonstrate that an acute exposure to COREXIT EC9500A exerts transient effects on cardiovascular and peripheral vascular functions.
No takes yet. Share an insight, caveat, or question.
Krajnak et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: